Global Tofacitinib Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
At What Rate is the Tofacitinib Market Predicted to Expand Between 2024 and 2033?
In past few years, the market size of tofacitinib has witnessed accelerated growth. The value is anticipated to rise from $2.76 billion in 2023 to $3.12 billion in 2024, which accounts for a compound annual growth rate (CAGR) of 13.0%. The notable expansion during the historic period is credited to its clinical effectiveness and trials, endorsement by regulatory entities, escalation in occurrence of specific conditions, physicians’ prescribing habits, and the acceptability among patients.
The market for tofacitinib is predicted to experience significant expansion in the coming years, with an anticipated market value of $5.02 billion in 2028 and a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period can be linked to broadened indications, initiatives to access the market, a competitive environment, practical evidence, and focus on patient-centric healthcare. Future trends predicted during this forecast period include an emphasis on treating pediatric rheumatoid arthritis, the use of tofacitinib for skin conditions, strategic cooperation and partnerships, incorporation of real-world evidence into treatment guidelines, and a focus on individualized medicine strategies.
Claim Your Free Sample of the Global Tofacitinib Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10779&type=smp
What Forces Are Boosting the tofacitinib Market’s Growth?
An upward trend in the occurrence of rheumatoid arthritis is anticipated to accelerate the expansion of the tofacitinib market. Rheumatoid arthritis, an autoimmune disease marked by inflammation, affects various body parts, including hands, feet, several other joints, and internal organs. Tofacitinib drugs work by stopping the Janus kinase enzymes from taking part in the inflammation that causes rheumatoid arthritis symptoms. As an illustration, according to the National Arthritis Data Workgroup, a group of epidemiology experts based in the US, it was reported that over 52.5 million American adults (equating to more than 22% of the population) were diagnosed with arthritis or a similar rheumatic condition in February 2022. By 2030, the number of adults aged 18 and older suffering from arthritis is expected to hit 67 million. Therefore, the increasing incidence of rheumatoid arthritis is fuelling the expansion of the tofacitinib market.
What Key Segments Make Up the Tofacitinib Market?
1) By Drug Class: Antirheumatic, Janus Kinase Inhibitor, Immunosuppressant
2) By Strength: 5mg, 10mg, 11mg, 22mg
3) By Route Of Administration: Oral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Other Applications
What Are the Latest Trends Impacting the Tofacitinib Market?
The emergence of product innovation is a prominent trend within the tofacitinib market. To maintain their market stronghold, primary companies in this industry are progressing towards the development of innovative products. For example, in December 2021, Pfizer Inc., a pharmaceutical and biotechnology corporation based in the US, announced its supplemental New Drug Application (sNDA) approval by the U.S. Food and Drug Administration (FDA) for its tofacitinib-based drugs; XELJANZ and XELJANZ XR. It’s worth noting that XELJANZ stands as the first-ever and sole Janus kinase (JAK) inhibitor approved in the US to treat five immuno-inflammatory illnesses. A Phase 3 study involving randomized, double-masked, placebo-controlled comparisons of the safety and efficacy of 5 mg tofacitinib, administered twice daily versus a placebo to 269 adult patients suffering from active AS laid the groundwork for approving XELJANZ for AS treatment.
Order Now for Fast Delivery of Your Tofacitinib Market Report!
https://www.thebusinessresearchcompany.com/report/tofacitinib-global-market-report
What Regions Are Dominating the Tofacitinib Market Growth?
North America was the largest region in the tofacitinib market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tofacitinib market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Tofacitinib Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the tofacitinib market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Tofacitinib Market Include
1. Tofacitinib Market Executive Summary
2. Tofacitinib Market Segments
3. Tofacitinib Market Size And Template Market Growth Rate
4. Key Tofacitinib Market Trends
5. Major Tofacitinib Market Drivers
……
25. Key Mergers And Acquisitions In The Tofacitinib Market
26. Top Tofacitinib Companies
27. Tofacitinib Market Opportunities And Strategies
28. Tofacitinib Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Circulating Tumor Cells Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024
Oilseeds Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oilseeds-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
